Rank | Gene Set | Z-score |
---|---|---|
1 | amino sugar catabolic process (GO:0046348) | 5.22119555 |
2 | N-acetylneuraminate metabolic process (GO:0006054) | 4.82471629 |
3 | negative regulation of interleukin-12 production (GO:0032695) | 4.66013529 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55937471 |
5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.49029196 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36309188 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36309188 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36309188 |
9 | modulation by symbiont of host immune response (GO:0052553) | 4.36309188 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36309188 |
11 | modulation by symbiont of host defense response (GO:0052031) | 4.36309188 |
12 | glycosphingolipid catabolic process (GO:0046479) | 4.19726078 |
13 | positive regulation of mast cell activation (GO:0033005) | 4.00283156 |
14 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.94779755 |
15 | positive regulation of mast cell degranulation (GO:0043306) | 3.94779755 |
16 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.94616465 |
17 | apoptotic cell clearance (GO:0043277) | 3.79608588 |
18 | cellular extravasation (GO:0045123) | 3.76391855 |
19 | macrophage activation involved in immune response (GO:0002281) | 3.72913186 |
20 | glycolipid catabolic process (GO:0019377) | 3.69645173 |
21 | regulation of mast cell degranulation (GO:0043304) | 3.65370406 |
22 | regulation of mononuclear cell migration (GO:0071675) | 3.50566636 |
23 | microglial cell activation (GO:0001774) | 3.46851836 |
24 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.41780992 |
25 | keratan sulfate catabolic process (GO:0042340) | 3.40868173 |
26 | oligosaccharide catabolic process (GO:0009313) | 3.39094074 |
27 | ceramide catabolic process (GO:0046514) | 3.37921373 |
28 | regulation of mast cell activation (GO:0033003) | 3.36225114 |
29 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.34265788 |
30 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.30227191 |
31 | negative regulation of granulocyte differentiation (GO:0030853) | 3.25287483 |
32 | reactive oxygen species biosynthetic process (GO:1903409) | 3.20744850 |
33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18221718 |
34 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.15360162 |
35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14688949 |
36 | adenosine receptor signaling pathway (GO:0001973) | 3.13673576 |
37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13052106 |
38 | response to host immune response (GO:0052572) | 3.13052106 |
39 | low-density lipoprotein particle clearance (GO:0034383) | 3.12043414 |
40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.11535795 |
41 | cellular response to cadmium ion (GO:0071276) | 3.10183387 |
42 | regulation of leukocyte degranulation (GO:0043300) | 3.09249848 |
43 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.05821067 |
44 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.05821067 |
45 | lysosome organization (GO:0007040) | 3.05552318 |
46 | lytic vacuole organization (GO:0080171) | 3.05552318 |
47 | barbed-end actin filament capping (GO:0051016) | 3.04326027 |
48 | response to host (GO:0075136) | 3.03087679 |
49 | response to host defenses (GO:0052200) | 3.03087679 |
50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03087679 |
51 | mannose metabolic process (GO:0006013) | 2.98607983 |
52 | intracellular pH reduction (GO:0051452) | 2.94818116 |
53 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.92172144 |
54 | immunoglobulin mediated immune response (GO:0016064) | 2.90923082 |
55 | plasma membrane repair (GO:0001778) | 2.90766694 |
56 | transferrin transport (GO:0033572) | 2.90584072 |
57 | positive regulation of chemokine secretion (GO:0090197) | 2.90451212 |
58 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.88132657 |
59 | virion attachment to host cell (GO:0019062) | 2.86933680 |
60 | adhesion of symbiont to host cell (GO:0044650) | 2.86933680 |
61 | negative regulation of mast cell activation (GO:0033004) | 2.80895316 |
62 | membrane lipid catabolic process (GO:0046466) | 2.79578084 |
63 | pH reduction (GO:0045851) | 2.78364756 |
64 | sphingolipid catabolic process (GO:0030149) | 2.78057776 |
65 | platelet dense granule organization (GO:0060155) | 2.75871127 |
66 | synaptic vesicle maturation (GO:0016188) | 2.75322159 |
67 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75214045 |
68 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.74834542 |
69 | regulation of regulated secretory pathway (GO:1903305) | 2.74283549 |
70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.73784502 |
71 | respiratory burst (GO:0045730) | 2.72416831 |
72 | trivalent inorganic cation transport (GO:0072512) | 2.70865498 |
73 | ferric iron transport (GO:0015682) | 2.70865498 |
74 | monocyte chemotaxis (GO:0002548) | 2.69382982 |
75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.68636429 |
76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66977165 |
77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.65468632 |
78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64720537 |
79 | negative regulation of cell killing (GO:0031342) | 2.64018740 |
80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64018740 |
81 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.63838661 |
82 | protein localization to endosome (GO:0036010) | 2.63825477 |
83 | neuromuscular process controlling posture (GO:0050884) | 2.63396522 |
84 | ganglioside metabolic process (GO:0001573) | 2.62544590 |
85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.62307275 |
86 | adhesion of symbiont to host (GO:0044406) | 2.61796773 |
87 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60512592 |
88 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.60448950 |
89 | myeloid dendritic cell differentiation (GO:0043011) | 2.59756695 |
90 | response to acidic pH (GO:0010447) | 2.59649680 |
91 | response to interferon-alpha (GO:0035455) | 2.59207996 |
92 | stress fiber assembly (GO:0043149) | 2.58178583 |
93 | positive regulation of heat generation (GO:0031652) | 2.58054738 |
94 | regulation of chemokine biosynthetic process (GO:0045073) | 2.57945396 |
95 | macrophage activation (GO:0042116) | 2.57627520 |
96 | positive regulation of macrophage cytokine production (GO:0060907) | 2.57103551 |
97 | positive regulation of interferon-alpha production (GO:0032727) | 2.56674938 |
98 | eosinophil chemotaxis (GO:0048245) | 2.55696782 |
99 | granulocyte activation (GO:0036230) | 2.54693229 |
100 | response to thyroid hormone (GO:0097066) | 2.53843024 |
101 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.53800193 |
102 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.52269170 |
103 | superoxide anion generation (GO:0042554) | 2.51417126 |
104 | cellular response to arsenic-containing substance (GO:0071243) | 2.51226011 |
105 | substrate-dependent cell migration (GO:0006929) | 2.50533059 |
106 | regulation of superoxide anion generation (GO:0032928) | 2.47687709 |
107 | pinocytosis (GO:0006907) | 2.46576733 |
108 | plasma lipoprotein particle clearance (GO:0034381) | 2.46317292 |
109 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.43606700 |
110 | positive regulation of regulated secretory pathway (GO:1903307) | 2.42003338 |
111 | cortical actin cytoskeleton organization (GO:0030866) | 2.41968764 |
112 | positive regulation of cholesterol efflux (GO:0010875) | 2.41807986 |
113 | synaptic vesicle exocytosis (GO:0016079) | 2.40737940 |
114 | cell communication by electrical coupling (GO:0010644) | 2.40458116 |
115 | cell adhesion mediated by integrin (GO:0033627) | 2.39875517 |
116 | negative regulation of interleukin-1 production (GO:0032692) | 2.38451936 |
117 | regulation of cholesterol storage (GO:0010885) | 2.36687336 |
118 | regulation of interferon-alpha production (GO:0032647) | 2.35644568 |
119 | chondroitin sulfate catabolic process (GO:0030207) | 2.35564924 |
120 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.34998905 |
121 | neutrophil activation involved in immune response (GO:0002283) | 2.32415038 |
122 | relaxation of cardiac muscle (GO:0055119) | 2.30760566 |
123 | cardiac myofibril assembly (GO:0055003) | 2.30449996 |
124 | * regulation of synapse structural plasticity (GO:0051823) | 2.28821430 |
125 | regulation of macrophage cytokine production (GO:0010935) | 2.24634938 |
126 | peptidyl-proline hydroxylation (GO:0019511) | 2.24076906 |
127 | cortical cytoskeleton organization (GO:0030865) | 2.23198033 |
128 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.23052592 |
129 | activation of protein kinase A activity (GO:0034199) | 2.23018818 |
130 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.22004893 |
131 | protein hydroxylation (GO:0018126) | 2.21731885 |
132 | I-kappaB phosphorylation (GO:0007252) | 2.21675895 |
133 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.21616022 |
134 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.20421902 |
135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.18491324 |
136 | positive regulation of p38MAPK cascade (GO:1900745) | 2.17131466 |
137 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.17033037 |
138 | negative regulation of interleukin-6 production (GO:0032715) | 2.16203750 |
139 | response to peptidoglycan (GO:0032494) | 2.15450167 |
140 | negative regulation of interleukin-17 production (GO:0032700) | 2.15281096 |
141 | regulation of p38MAPK cascade (GO:1900744) | 2.14682455 |
142 | sodium ion export (GO:0071436) | 2.14110867 |
143 | alanine transport (GO:0032328) | 2.13347063 |
144 | hyaluronan catabolic process (GO:0030214) | 2.12381111 |
145 | endothelial cell chemotaxis (GO:0035767) | 2.11506450 |
146 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.11029616 |
147 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.10346194 |
148 | protein retention in ER lumen (GO:0006621) | 2.10331390 |
149 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.10145660 |
150 | phagocytosis, engulfment (GO:0006911) | 2.09511671 |
151 | toxin transport (GO:1901998) | 2.09074722 |
152 | macrophage differentiation (GO:0030225) | 2.08692265 |
153 | endosome to pigment granule transport (GO:0043485) | 2.07826348 |
154 | endosome to melanosome transport (GO:0035646) | 2.07826348 |
155 | regulation of cell communication by electrical coupling (GO:0010649) | 2.07431986 |
156 | cytokine production involved in immune response (GO:0002367) | 2.05821322 |
157 | heparin metabolic process (GO:0030202) | 2.05036329 |
158 | heparin biosynthetic process (GO:0030210) | 2.05036329 |
159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.04530330 |
160 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.04007131 |
161 | regulation of macrophage chemotaxis (GO:0010758) | 2.02936211 |
162 | response to fluid shear stress (GO:0034405) | 2.02334037 |
163 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.02108460 |
164 | detection of molecule of bacterial origin (GO:0032490) | 2.02060687 |
165 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.00152508 |
166 | regulation of calcium ion transmembrane transport (GO:1903169) | 1.99861949 |
167 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 1.99861949 |
168 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.99154679 |
169 | phagosome maturation (GO:0090382) | 1.98808484 |
170 | platelet aggregation (GO:0070527) | 1.98695509 |
171 | phosphatidylglycerol biosynthetic process (GO:0006655) | 1.98069270 |
172 | myeloid cell activation involved in immune response (GO:0002275) | 1.97900066 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.16084029 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.11064761 |
3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.86234915 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50842060 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35679154 |
6 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35646766 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28756462 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26860515 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17781562 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14542158 |
11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99744145 |
12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.99549904 |
13 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.94581219 |
14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94575634 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93865518 |
16 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92370484 |
17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89364665 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88331441 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83156521 |
20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.80000554 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78946854 |
22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74704318 |
23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.72564724 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70228579 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67854070 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65061047 |
27 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64449527 |
28 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63891054 |
29 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59819098 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56278981 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55577852 |
32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53000453 |
33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52878742 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52696996 |
35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52152109 |
36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49513007 |
37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48310323 |
38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48282270 |
39 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46877478 |
40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46462045 |
41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46031808 |
42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44293623 |
43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43982129 |
44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43394427 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42021445 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41421287 |
47 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.40827350 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40668148 |
49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40280300 |
50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38632380 |
51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37578733 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37377132 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36767380 |
54 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36568485 |
55 | * P68_20966046_ChIP-Seq_HELA_Human | 1.34174329 |
56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32874736 |
57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31679596 |
58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31580617 |
59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31081300 |
60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30707215 |
61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29697864 |
62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27968480 |
63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27936705 |
64 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26577341 |
65 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25154639 |
66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24164177 |
67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.23941153 |
68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22734607 |
69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22734607 |
70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22645344 |
71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21209119 |
72 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20958458 |
73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20890996 |
74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20781616 |
75 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20631626 |
76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20584483 |
77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19195077 |
78 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19064478 |
79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18799158 |
80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18104269 |
81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17878957 |
82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17850614 |
83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17710740 |
84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17710740 |
85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17700361 |
86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17329997 |
87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16275093 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16259722 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16150812 |
90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15639305 |
91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15628596 |
92 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14833898 |
93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12674450 |
94 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12153301 |
95 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12102836 |
96 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11972222 |
97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11084441 |
98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10509204 |
99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.10196022 |
100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10034472 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08133616 |
102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07810420 |
103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07711325 |
104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07116943 |
105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06897526 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06874952 |
107 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06214867 |
108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06155086 |
109 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.05960452 |
110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05686289 |
111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05549423 |
112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04891067 |
113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04855269 |
114 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04766170 |
115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04101783 |
116 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.04031197 |
117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03797075 |
118 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03178173 |
119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02997970 |
120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02746740 |
121 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02715964 |
122 | MAF_26560356_Chip-Seq_TH2_Human | 1.02230376 |
123 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02064113 |
124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01960633 |
125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99457018 |
126 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.99265913 |
127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99247335 |
128 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99104189 |
129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98049304 |
130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97905268 |
131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97254435 |
132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96861633 |
133 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96837701 |
134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95866681 |
135 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95554189 |
136 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95377597 |
137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94905251 |
138 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.94765469 |
139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94555905 |
140 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92778492 |
141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92425447 |
142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92341573 |
143 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91997495 |
144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91753202 |
145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89518949 |
146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89371060 |
147 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89261567 |
148 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88967588 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.23534877 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.85467576 |
3 | MP0003172_abnormal_lysosome_physiology | 2.94801599 |
4 | MP0003191_abnormal_cellular_cholesterol | 2.75665282 |
5 | MP0004858_abnormal_nervous_system | 2.73859119 |
6 | MP0000751_myopathy | 2.61044502 |
7 | MP0004130_abnormal_muscle_cell | 2.52393001 |
8 | MP0009840_abnormal_foam_cell | 2.46480725 |
9 | MP0001958_emphysema | 2.45621307 |
10 | MP0003279_aneurysm | 2.30231456 |
11 | MP0004510_myositis | 2.27479424 |
12 | MP0003075_altered_response_to | 2.19436959 |
13 | MP0009785_altered_susceptibility_to | 2.12753042 |
14 | MP0003329_amyloid_beta_deposits | 2.07530461 |
15 | MP0002139_abnormal_hepatobiliary_system | 2.07004859 |
16 | MP0000343_altered_response_to | 2.02705945 |
17 | MP0004084_abnormal_cardiac_muscle | 2.01097112 |
18 | MP0010368_abnormal_lymphatic_system | 1.99241112 |
19 | MP0005671_abnormal_response_to | 1.98746917 |
20 | MP0002909_abnormal_adrenal_gland | 1.97613459 |
21 | MP0005000_abnormal_immune_tolerance | 1.91350023 |
22 | MP0005670_abnormal_white_adipose | 1.90969807 |
23 | MP0003303_peritoneal_inflammation | 1.86350763 |
24 | MP0009764_decreased_sensitivity_to | 1.85201186 |
25 | MP0001790_abnormal_immune_system | 1.79578921 |
26 | MP0005387_immune_system_phenotype | 1.79578921 |
27 | MP0002837_dystrophic_cardiac_calcinosis | 1.79545523 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.79056792 |
29 | MP0003566_abnormal_cell_adhesion | 1.75815755 |
30 | MP0003879_abnormal_hair_cell | 1.75187395 |
31 | MP0000749_muscle_degeneration | 1.68916204 |
32 | MP0005365_abnormal_bile_salt | 1.68811080 |
33 | MP0000920_abnormal_myelination | 1.65271649 |
34 | MP0003828_pulmonary_edema | 1.61001779 |
35 | MP0002064_seizures | 1.58748156 |
36 | MP0000569_abnormal_digit_pigmentation | 1.58680680 |
37 | MP0009278_abnormal_bone_marrow | 1.56232668 |
38 | MP0003436_decreased_susceptibility_to | 1.56138917 |
39 | MP0002419_abnormal_innate_immunity | 1.54541531 |
40 | MP0003195_calcinosis | 1.52976924 |
41 | MP0001533_abnormal_skeleton_physiology | 1.52627775 |
42 | MP0002723_abnormal_immune_serum | 1.52190791 |
43 | MP0000750_abnormal_muscle_regeneration | 1.49663452 |
44 | MP0005464_abnormal_platelet_physiology | 1.46567130 |
45 | MP0005275_abnormal_skin_tensile | 1.44089971 |
46 | MP0000685_abnormal_immune_system | 1.43449804 |
47 | MP0005310_abnormal_salivary_gland | 1.43296205 |
48 | MP0006082_CNS_inflammation | 1.42383848 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.40352085 |
50 | MP0001845_abnormal_inflammatory_respons | 1.37498496 |
51 | MP0003724_increased_susceptibility_to | 1.36998345 |
52 | MP0004484_altered_response_of | 1.36277257 |
53 | MP0003806_abnormal_nucleotide_metabolis | 1.35800122 |
54 | MP0004859_abnormal_synaptic_plasticity | 1.34372379 |
55 | MP0002420_abnormal_adaptive_immunity | 1.33072638 |
56 | MP0003300_gastrointestinal_ulcer | 1.31642628 |
57 | MP0001853_heart_inflammation | 1.31514086 |
58 | MP0001819_abnormal_immune_cell | 1.31292478 |
59 | MP0001835_abnormal_antigen_presentation | 1.29128039 |
60 | MP0004036_abnormal_muscle_relaxation | 1.28366335 |
61 | MP0004215_abnormal_myocardial_fiber | 1.27900120 |
62 | MP0005165_increased_susceptibility_to | 1.26924517 |
63 | MP0002090_abnormal_vision | 1.24216435 |
64 | MP0001800_abnormal_humoral_immune | 1.22836994 |
65 | MP0002972_abnormal_cardiac_muscle | 1.22550038 |
66 | MP0002405_respiratory_system_inflammati | 1.22213754 |
67 | MP0005166_decreased_susceptibility_to | 1.22090700 |
68 | MP0002998_abnormal_bone_remodeling | 1.21081284 |
69 | MP0003690_abnormal_glial_cell | 1.19579965 |
70 | MP0004272_abnormal_basement_membrane | 1.17489346 |
71 | MP0008004_abnormal_stomach_pH | 1.16929987 |
72 | MP0000013_abnormal_adipose_tissue | 1.14674703 |
73 | MP0000747_muscle_weakness | 1.14270494 |
74 | MP0005330_cardiomyopathy | 1.12639716 |
75 | MP0003183_abnormal_peptide_metabolism | 1.11873375 |
76 | MP0005595_abnormal_vascular_smooth | 1.10705097 |
77 | MP0000767_abnormal_smooth_muscle | 1.08943849 |
78 | MP0009046_muscle_twitch | 1.08666032 |
79 | MP0009115_abnormal_fat_cell | 1.08572482 |
80 | MP0004087_abnormal_muscle_fiber | 1.07736692 |
81 | MP0001501_abnormal_sleep_pattern | 1.07351594 |
82 | MP0005666_abnormal_adipose_tissue | 1.06208979 |
83 | MP0003880_abnormal_central_pattern | 1.05647843 |
84 | MP0001879_abnormal_lymphatic_vessel | 1.05584064 |
85 | MP0008874_decreased_physiological_sensi | 1.05124314 |
86 | MP0001984_abnormal_olfaction | 1.03191466 |
87 | MP0005503_abnormal_tendon_morphology | 1.02472318 |
88 | MP0000465_gastrointestinal_hemorrhage | 1.02342782 |
89 | MP0003635_abnormal_synaptic_transmissio | 1.02288902 |
90 | MP0008775_abnormal_heart_ventricle | 1.01090879 |
91 | MP0009745_abnormal_behavioral_response | 1.00838547 |
92 | MP0003646_muscle_fatigue | 1.00259632 |
93 | MP0003631_nervous_system_phenotype | 1.00241612 |
94 | MP0002063_abnormal_learning/memory/cond | 0.98399264 |
95 | MP0002933_joint_inflammation | 0.97535634 |
96 | MP0005385_cardiovascular_system_phenoty | 0.95888380 |
97 | MP0001544_abnormal_cardiovascular_syste | 0.95888380 |
98 | MP0000858_altered_metastatic_potential | 0.95501392 |
99 | MP0004185_abnormal_adipocyte_glucose | 0.93833404 |
100 | MP0001970_abnormal_pain_threshold | 0.93586822 |
101 | MP0003448_altered_tumor_morphology | 0.93501132 |
102 | MP0003091_abnormal_cell_migration | 0.93480023 |
103 | MP0000604_amyloidosis | 0.93459256 |
104 | MP0005397_hematopoietic_system_phenotyp | 0.92985367 |
105 | MP0001545_abnormal_hematopoietic_system | 0.92985367 |
106 | MP0005375_adipose_tissue_phenotype | 0.92179634 |
107 | MP0005620_abnormal_muscle_contractility | 0.91799306 |
108 | MP0010329_abnormal_lipoprotein_level | 0.91515497 |
109 | MP0005623_abnormal_meninges_morphology | 0.90613313 |
110 | MP0003011_delayed_dark_adaptation | 0.89405690 |
111 | MP0004145_abnormal_muscle_electrophysio | 0.89069905 |
112 | MP0005083_abnormal_biliary_tract | 0.88741906 |
113 | MP0002971_abnormal_brown_adipose | 0.87393237 |
114 | MP0002295_abnormal_pulmonary_circulatio | 0.86545368 |
115 | MP0005535_abnormal_body_temperature | 0.86193985 |
116 | MP0000230_abnormal_systemic_arterial | 0.84622749 |
117 | MP0002148_abnormal_hypersensitivity_rea | 0.83648653 |
118 | MP0009333_abnormal_splenocyte_physiolog | 0.83610143 |
119 | MP0005451_abnormal_body_composition | 0.83559181 |
120 | MP0002118_abnormal_lipid_homeostasis | 0.83062851 |
121 | MP0002277_abnormal_respiratory_mucosa | 0.83051645 |
122 | MP0004742_abnormal_vestibular_system | 0.82107292 |
123 | MP0002106_abnormal_muscle_physiology | 0.81581086 |
124 | MP0005390_skeleton_phenotype | 0.81108507 |
125 | MP0003186_abnormal_redox_activity | 0.80457379 |
126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79628532 |
127 | MP0000249_abnormal_blood_vessel | 0.79143267 |
128 | MP0003045_fibrosis | 0.78344354 |
129 | MP0001542_abnormal_bone_strength | 0.78029682 |
130 | MP0008260_abnormal_autophagy | 0.77028526 |
131 | MP0002269_muscular_atrophy | 0.77004241 |
132 | MP0000759_abnormal_skeletal_muscle | 0.76364586 |
133 | MP0002733_abnormal_thermal_nociception | 0.76362772 |
134 | MP0004947_skin_inflammation | 0.76265514 |
135 | MP0001663_abnormal_digestive_system | 0.76034678 |
136 | MP0008469_abnormal_protein_level | 0.76013723 |
137 | MP0001440_abnormal_grooming_behavior | 0.75873106 |
138 | MP0000716_abnormal_immune_system | 0.75260597 |
139 | MP0005025_abnormal_response_to | 0.74980158 |
140 | MP0004085_abnormal_heartbeat | 0.74901615 |
141 | MP0002396_abnormal_hematopoietic_system | 0.74556371 |
142 | MP0001968_abnormal_touch/_nociception | 0.74544255 |
143 | MP0002229_neurodegeneration | 0.74286985 |
144 | MP0005164_abnormal_response_to | 0.73984423 |
145 | MP0002572_abnormal_emotion/affect_behav | 0.73049587 |
146 | MP0002452_abnormal_antigen_presenting | 0.72967675 |
147 | MP0003632_abnormal_nervous_system | 0.72392459 |
148 | MP0003634_abnormal_glial_cell | 0.71823601 |
149 | MP0003633_abnormal_nervous_system | 0.71586772 |
150 | MP0002896_abnormal_bone_mineralization | 0.70331170 |
151 | MP0000003_abnormal_adipose_tissue | 0.69630127 |
152 | MP0004883_abnormal_blood_vessel | 0.69405898 |
153 | MP0005174_abnormal_tail_pigmentation | 0.68987784 |
154 | MP0001873_stomach_inflammation | 0.68942025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 4.83099465 |
2 | Increased cerebral lipofuscin (HP:0011813) | 4.75259209 |
3 | Dysostosis multiplex (HP:0000943) | 4.59742633 |
4 | Cerebral aneurysm (HP:0004944) | 4.15090645 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06664926 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06664926 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06664926 |
8 | Vacuolated lymphocytes (HP:0001922) | 4.04604458 |
9 | Asymmetric septal hypertrophy (HP:0001670) | 4.01444161 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.98224936 |
11 | Mucopolysacchariduria (HP:0008155) | 3.74423796 |
12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.74423796 |
13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.64247668 |
14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.64247668 |
15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.64247668 |
16 | Glomerulonephritis (HP:0000099) | 3.57842042 |
17 | Upper motor neuron abnormality (HP:0002127) | 3.47106734 |
18 | Neurofibrillary tangles (HP:0002185) | 3.42333357 |
19 | Hand muscle atrophy (HP:0009130) | 3.29533533 |
20 | Autoimmune thrombocytopenia (HP:0001973) | 3.16031099 |
21 | Loss of speech (HP:0002371) | 3.15411673 |
22 | Arterial tortuosity (HP:0005116) | 3.11177920 |
23 | Protrusio acetabuli (HP:0003179) | 3.09597329 |
24 | Amyloidosis (HP:0011034) | 3.05254030 |
25 | Agnosia (HP:0010524) | 2.97364936 |
26 | Aortic aneurysm (HP:0004942) | 2.96663949 |
27 | Distal upper limb amyotrophy (HP:0007149) | 2.94920284 |
28 | Upper limb amyotrophy (HP:0009129) | 2.94920284 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.92594866 |
30 | Vascular tortuosity (HP:0004948) | 2.92054178 |
31 | Mutism (HP:0002300) | 2.88690180 |
32 | Obstructive lung disease (HP:0006536) | 2.88657581 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88657581 |
34 | Recurrent abscess formation (HP:0002722) | 2.85663088 |
35 | Purpura (HP:0000979) | 2.78223602 |
36 | Inappropriate behavior (HP:0000719) | 2.76862518 |
37 | Axonal loss (HP:0003447) | 2.76787637 |
38 | Stomatitis (HP:0010280) | 2.75413671 |
39 | Apathy (HP:0000741) | 2.73670111 |
40 | Aortic dissection (HP:0002647) | 2.73118985 |
41 | Bone cyst (HP:0012062) | 2.69149160 |
42 | Myocardial infarction (HP:0001658) | 2.67218278 |
43 | Broad metatarsal (HP:0001783) | 2.65504331 |
44 | Premature rupture of membranes (HP:0001788) | 2.64743724 |
45 | Vertebral compression fractures (HP:0002953) | 2.64334470 |
46 | Nuclear cataract (HP:0100018) | 2.64181165 |
47 | Cerebral inclusion bodies (HP:0100314) | 2.62574151 |
48 | Myositis (HP:0100614) | 2.58342740 |
49 | Striae distensae (HP:0001065) | 2.57401685 |
50 | J-shaped sella turcica (HP:0002680) | 2.56851469 |
51 | Complement deficiency (HP:0004431) | 2.56424234 |
52 | Retinal atrophy (HP:0001105) | 2.54499854 |
53 | Dementia (HP:0000726) | 2.52809509 |
54 | Hepatosplenomegaly (HP:0001433) | 2.49303534 |
55 | Hematochezia (HP:0002573) | 2.49229600 |
56 | Joint stiffness (HP:0001387) | 2.45692730 |
57 | Ankle contracture (HP:0006466) | 2.44387196 |
58 | Tetraparesis (HP:0002273) | 2.44375221 |
59 | Orchitis (HP:0100796) | 2.43193759 |
60 | Cervical subluxation (HP:0003308) | 2.43186988 |
61 | Progressive neurologic deterioration (HP:0002344) | 2.43020976 |
62 | Recurrent bacterial skin infections (HP:0005406) | 2.39165649 |
63 | Personality changes (HP:0000751) | 2.38201276 |
64 | Recurrent skin infections (HP:0001581) | 2.38111265 |
65 | Prolonged neonatal jaundice (HP:0006579) | 2.32639458 |
66 | Global brain atrophy (HP:0002283) | 2.32060460 |
67 | Abnormality of complement system (HP:0005339) | 2.30463060 |
68 | Visual hallucinations (HP:0002367) | 2.28127714 |
69 | Abnormality of macrophages (HP:0004311) | 2.23414708 |
70 | Ovoid vertebral bodies (HP:0003300) | 2.22916371 |
71 | Nephritis (HP:0000123) | 2.21964693 |
72 | Optic neuritis (HP:0100653) | 2.21885610 |
73 | Retrobulbar optic neuritis (HP:0100654) | 2.21885610 |
74 | Xanthomatosis (HP:0000991) | 2.21476356 |
75 | Beaking of vertebral bodies (HP:0004568) | 2.18954906 |
76 | Neuronal loss in central nervous system (HP:0002529) | 2.16665730 |
77 | Increased serum ferritin (HP:0003281) | 2.16459709 |
78 | Petechiae (HP:0000967) | 2.14685036 |
79 | Eczematoid dermatitis (HP:0000976) | 2.12719694 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.11137544 |
81 | Abnormality of the periventricular white matter (HP:0002518) | 2.10882337 |
82 | Disinhibition (HP:0000734) | 2.10421767 |
83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09941859 |
84 | Gingivitis (HP:0000230) | 2.08897360 |
85 | Difficulty climbing stairs (HP:0003551) | 2.08361019 |
86 | Atrial fibrillation (HP:0005110) | 2.08125935 |
87 | Thoracic kyphosis (HP:0002942) | 2.02417870 |
88 | Mesangial abnormality (HP:0001966) | 1.99236121 |
89 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98698049 |
90 | Sudden death (HP:0001699) | 1.98509742 |
91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97486632 |
92 | Abnormality of binocular vision (HP:0011514) | 1.97399245 |
93 | Diplopia (HP:0000651) | 1.97399245 |
94 | Type 1 muscle fiber predominance (HP:0003803) | 1.96475736 |
95 | Spinal rigidity (HP:0003306) | 1.95914624 |
96 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95213667 |
97 | Growth hormone excess (HP:0000845) | 1.94618532 |
98 | Aneurysm (HP:0002617) | 1.94589855 |
99 | Primary atrial arrhythmia (HP:0001692) | 1.94339657 |
100 | Esophageal neoplasm (HP:0100751) | 1.94332002 |
101 | Neoplasm of head and neck (HP:0012288) | 1.94332002 |
102 | Myotonia (HP:0002486) | 1.92662828 |
103 | Oligomenorrhea (HP:0000876) | 1.92401775 |
104 | Memory impairment (HP:0002354) | 1.91288047 |
105 | Myokymia (HP:0002411) | 1.90740292 |
106 | Lipoatrophy (HP:0100578) | 1.90617705 |
107 | Shallow orbits (HP:0000586) | 1.90303788 |
108 | Soft skin (HP:0000977) | 1.88969155 |
109 | Rapidly progressive (HP:0003678) | 1.88739872 |
110 | Peripheral demyelination (HP:0011096) | 1.88728750 |
111 | Spontaneous hematomas (HP:0007420) | 1.88473398 |
112 | Delusions (HP:0000746) | 1.88112949 |
113 | Supraventricular tachycardia (HP:0004755) | 1.87028309 |
114 | Palpitations (HP:0001962) | 1.86949060 |
115 | Supraventricular arrhythmia (HP:0005115) | 1.86209160 |
116 | Abnormal eating behavior (HP:0100738) | 1.85241284 |
117 | Agitation (HP:0000713) | 1.84959689 |
118 | Cardiomegaly (HP:0001640) | 1.84244434 |
119 | Recurrent fungal infections (HP:0002841) | 1.84085866 |
120 | Generalized amyotrophy (HP:0003700) | 1.82421483 |
121 | Abnormality of the lumbar spine (HP:0100712) | 1.81907964 |
122 | Ventricular tachycardia (HP:0004756) | 1.80439339 |
123 | Frequent falls (HP:0002359) | 1.79562827 |
124 | Pathologic fracture (HP:0002756) | 1.77665174 |
125 | Progressive visual loss (HP:0000529) | 1.77294987 |
126 | Bundle branch block (HP:0011710) | 1.77173627 |
127 | Exercise-induced muscle cramps (HP:0003710) | 1.77009233 |
128 | Diminished motivation (HP:0000745) | 1.76879149 |
129 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76839523 |
130 | Dilatation of the ascending aorta (HP:0005111) | 1.75517365 |
131 | Achilles tendon contracture (HP:0001771) | 1.75091133 |
132 | Mitral valve prolapse (HP:0001634) | 1.74833927 |
133 | Polyphagia (HP:0002591) | 1.74829287 |
134 | Pulmonary infiltrates (HP:0002113) | 1.74532611 |
135 | Facial diplegia (HP:0001349) | 1.74320317 |
136 | Supranuclear gaze palsy (HP:0000605) | 1.74313145 |
137 | Enlarged penis (HP:0000040) | 1.74062440 |
138 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73894658 |
139 | Myoclonus (HP:0001336) | 1.73790507 |
140 | Spondylolisthesis (HP:0003302) | 1.73705862 |
141 | Muscle fiber splitting (HP:0003555) | 1.72615228 |
142 | Increased connective tissue (HP:0009025) | 1.71781702 |
143 | Metaphyseal irregularity (HP:0003025) | 1.71763358 |
144 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71374080 |
145 | Hemoptysis (HP:0002105) | 1.71259874 |
146 | Abnormality of the motor neurons (HP:0002450) | 1.70851972 |
147 | Abnormal neuron morphology (HP:0012757) | 1.70851972 |
148 | Basal ganglia calcification (HP:0002135) | 1.69131454 |
149 | Deformed sella turcica (HP:0002681) | 1.68824032 |
150 | Bladder diverticulum (HP:0000015) | 1.67774298 |
151 | Urticaria (HP:0001025) | 1.67662312 |
152 | Polygenic inheritance (HP:0010982) | 1.67492856 |
153 | Fragile skin (HP:0001030) | 1.67057128 |
154 | Nausea (HP:0002018) | 1.66499662 |
155 | Abnormality of iron homeostasis (HP:0011031) | 1.65624092 |
156 | Polyneuropathy (HP:0001271) | 1.64602603 |
157 | Hemiplegia (HP:0002301) | 1.63949409 |
158 | Increased CSF protein (HP:0002922) | 1.59972961 |
159 | Meningitis (HP:0001287) | 1.56587328 |
160 | Spastic tetraparesis (HP:0001285) | 1.54567399 |
161 | Bone pain (HP:0002653) | 1.53432595 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 4.39124542 |
2 | IRAK3 | 3.67338653 |
3 | TRIB3 | 3.64989445 |
4 | TTN | 2.93645644 |
5 | RIPK1 | 2.83609642 |
6 | ERN1 | 2.72351102 |
7 | NME2 | 2.69568094 |
8 | KIT | 2.55687238 |
9 | PKN2 | 2.52899826 |
10 | ARAF | 2.35150537 |
11 | TBK1 | 2.11280368 |
12 | SCYL2 | 1.99655522 |
13 | MAP3K9 | 1.91704737 |
14 | MYLK | 1.88418069 |
15 | RIPK4 | 1.83314479 |
16 | ABL2 | 1.77652197 |
17 | TESK1 | 1.77511385 |
18 | TIE1 | 1.72784204 |
19 | EPHA4 | 1.70683019 |
20 | CSF1R | 1.65748353 |
21 | CSK | 1.58712177 |
22 | MAP2K3 | 1.56040416 |
23 | KSR2 | 1.49998063 |
24 | FGR | 1.48698321 |
25 | LMTK2 | 1.46511731 |
26 | GRK7 | 1.45871700 |
27 | TAOK2 | 1.44855079 |
28 | MAP4K1 | 1.44756871 |
29 | PHKG2 | 1.44047503 |
30 | PHKG1 | 1.44047503 |
31 | PRKD3 | 1.42344229 |
32 | PAK4 | 1.39603183 |
33 | DAPK2 | 1.37822128 |
34 | CCNB1 | 1.36724859 |
35 | TESK2 | 1.35188208 |
36 | PRPF4B | 1.32811136 |
37 | FES | 1.31270007 |
38 | PDGFRA | 1.28919919 |
39 | TNK2 | 1.23197916 |
40 | LRRK2 | 1.22195524 |
41 | DAPK3 | 1.19724898 |
42 | ACVR1B | 1.19296905 |
43 | ADRBK2 | 1.17514246 |
44 | TYK2 | 1.16283058 |
45 | MATK | 1.15319190 |
46 | IKBKB | 1.14630480 |
47 | PTK6 | 1.12761313 |
48 | MOS | 1.12623494 |
49 | TLK1 | 1.11792534 |
50 | SIK1 | 1.10260486 |
51 | BLK | 1.07212242 |
52 | MAP3K13 | 1.06186597 |
53 | MAP3K12 | 1.03824631 |
54 | DDR2 | 1.03210020 |
55 | MAPKAPK3 | 1.02014163 |
56 | BCKDK | 1.00311993 |
57 | PAK6 | 1.00163998 |
58 | PIM2 | 0.99552180 |
59 | IRAK2 | 0.97023219 |
60 | PRKG2 | 0.90432576 |
61 | IRAK4 | 0.87940788 |
62 | MAPKAPK5 | 0.87717616 |
63 | TYRO3 | 0.87648533 |
64 | MAP3K14 | 0.86623611 |
65 | CDC42BPA | 0.86171819 |
66 | FLT3 | 0.85884785 |
67 | MAP2K1 | 0.85845950 |
68 | ILK | 0.85428662 |
69 | SIK2 | 0.83898351 |
70 | NTRK3 | 0.83666912 |
71 | MAPK15 | 0.83145943 |
72 | RET | 0.83057397 |
73 | ZAP70 | 0.83034421 |
74 | MAPK12 | 0.81810424 |
75 | EPHB2 | 0.81430155 |
76 | JAK3 | 0.81121202 |
77 | MAP2K6 | 0.81050312 |
78 | * CAMKK1 | 0.78653421 |
79 | MARK2 | 0.77439222 |
80 | DAPK1 | 0.76327830 |
81 | LYN | 0.75836412 |
82 | MST1R | 0.75020327 |
83 | PDPK1 | 0.74488309 |
84 | JAK1 | 0.74128333 |
85 | MAP3K4 | 0.73743324 |
86 | MAP3K7 | 0.73591695 |
87 | MAP2K4 | 0.73393717 |
88 | HCK | 0.71995150 |
89 | NTRK1 | 0.71821084 |
90 | RAF1 | 0.71296348 |
91 | PAK2 | 0.70961792 |
92 | CSNK1G3 | 0.70207251 |
93 | NEK9 | 0.69565262 |
94 | PINK1 | 0.69263374 |
95 | MAP3K3 | 0.67068531 |
96 | RPS6KA2 | 0.66739226 |
97 | IKBKE | 0.64668489 |
98 | PRKCG | 0.64648335 |
99 | * CAMK1 | 0.63353357 |
100 | PAK3 | 0.63031511 |
101 | MAP3K1 | 0.63029055 |
102 | PRKCH | 0.62901681 |
103 | TAOK1 | 0.62796546 |
104 | FER | 0.60355628 |
105 | PTK2B | 0.59896301 |
106 | PRKD2 | 0.58646859 |
107 | CSNK1G2 | 0.58450183 |
108 | DMPK | 0.56208973 |
109 | CDK19 | 0.55204348 |
110 | EPHB1 | 0.54333875 |
111 | PDK1 | 0.52922292 |
112 | LIMK1 | 0.51931342 |
113 | MAP3K11 | 0.51556632 |
114 | PRKD1 | 0.51297211 |
115 | CSNK1A1L | 0.50711751 |
116 | KDR | 0.50638297 |
117 | MAP2K2 | 0.50588396 |
118 | RPS6KA6 | 0.49559447 |
119 | PKN1 | 0.49442392 |
120 | TRPM7 | 0.48899808 |
121 | MAP3K5 | 0.48841105 |
122 | MUSK | 0.48170947 |
123 | STK38 | 0.47912076 |
124 | TXK | 0.47891096 |
125 | PIK3CG | 0.47627126 |
126 | LCK | 0.46655206 |
127 | SMG1 | 0.46390375 |
128 | BMPR2 | 0.46077569 |
129 | JAK2 | 0.45317293 |
130 | CAMK2D | 0.45235538 |
131 | MAPK4 | 0.44984086 |
132 | MINK1 | 0.43189627 |
133 | PTK2 | 0.42751552 |
134 | SYK | 0.42705501 |
135 | RPS6KC1 | 0.42395776 |
136 | RPS6KL1 | 0.42395776 |
137 | EEF2K | 0.41564633 |
138 | STK11 | 0.41372244 |
139 | CDK14 | 0.40720395 |
140 | GRK5 | 0.40009199 |
141 | TEC | 0.39130271 |
142 | CDK15 | 0.38544302 |
143 | * CAMK4 | 0.38028233 |
144 | PRKCE | 0.37640203 |
145 | MAP2K7 | 0.37269496 |
146 | SRC | 0.37247394 |
147 | CDK5 | 0.37125404 |
148 | PIK3CA | 0.37021483 |
149 | ADRBK1 | 0.35695683 |
150 | CDK11A | 0.33624031 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.31805223 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02846429 |
3 | Lysosome_Homo sapiens_hsa04142 | 2.89395309 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11072468 |
5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.00455175 |
6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.73335354 |
7 | Pertussis_Homo sapiens_hsa05133 | 1.71828467 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 1.67214655 |
9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62283558 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 1.60443485 |
11 | Phagosome_Homo sapiens_hsa04145 | 1.55960485 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54913387 |
13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54836583 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54211699 |
15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53668550 |
16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52295913 |
17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50678140 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50476771 |
19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45882936 |
20 | Asthma_Homo sapiens_hsa05310 | 1.45768803 |
21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.41345616 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37317005 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37170425 |
24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36354121 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34306241 |
26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33342431 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.29364384 |
28 | Prion diseases_Homo sapiens_hsa05020 | 1.27240418 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26356943 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25114149 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22778356 |
32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21548024 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.21419688 |
34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20291885 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19588354 |
36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14737755 |
37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13562679 |
38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12013433 |
39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11625091 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08280220 |
41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07400897 |
42 | Malaria_Homo sapiens_hsa05144 | 1.07026756 |
43 | Salmonella infection_Homo sapiens_hsa05132 | 1.05795144 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04871478 |
45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04708922 |
46 | Focal adhesion_Homo sapiens_hsa04510 | 1.04572044 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02816570 |
48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00830467 |
49 | Amoebiasis_Homo sapiens_hsa05146 | 1.00150515 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99668111 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99576532 |
52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98918340 |
53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97338746 |
54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95318171 |
55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95102162 |
56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93433177 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.91225657 |
58 | Endocytosis_Homo sapiens_hsa04144 | 0.90418027 |
59 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90174166 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87345409 |
61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86387668 |
62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85157910 |
63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85009656 |
64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82402314 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82173409 |
66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82011403 |
67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81961530 |
68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81840301 |
69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80030167 |
70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79376736 |
71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79042391 |
72 | Insulin resistance_Homo sapiens_hsa04931 | 0.78295104 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.78288608 |
74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76531170 |
75 | Salivary secretion_Homo sapiens_hsa04970 | 0.74148700 |
76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74005511 |
77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73386066 |
78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73203196 |
79 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72945182 |
80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72103590 |
81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71231131 |
82 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70901109 |
83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70378851 |
84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69761589 |
85 | Legionellosis_Homo sapiens_hsa05134 | 0.69460968 |
86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69285627 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69070855 |
88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68119312 |
89 | Renin secretion_Homo sapiens_hsa04924 | 0.68031660 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67376194 |
91 | Glioma_Homo sapiens_hsa05214 | 0.67353307 |
92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67231305 |
93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66948698 |
94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64784827 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62893308 |
96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62581751 |
97 | Gap junction_Homo sapiens_hsa04540 | 0.62282016 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61934227 |
99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61931064 |
100 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61177750 |
101 | Apoptosis_Homo sapiens_hsa04210 | 0.61054449 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60069640 |
103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59988595 |
104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58079799 |
105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57805993 |
106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55072527 |
107 | Insulin secretion_Homo sapiens_hsa04911 | 0.54846509 |
108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54091842 |
109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53850363 |
110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52674130 |
111 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52499559 |
112 | Morphine addiction_Homo sapiens_hsa05032 | 0.52059616 |
113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52031125 |
114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51649705 |
115 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51624847 |
116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51522785 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51323066 |
118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50883520 |
119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50710199 |
120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49381080 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49028822 |
122 | Influenza A_Homo sapiens_hsa05164 | 0.48971312 |
123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47973781 |
124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47624735 |
125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46730208 |
126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46559945 |
127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46540691 |
128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45946134 |
129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45344142 |
130 | Bladder cancer_Homo sapiens_hsa05219 | 0.44692380 |
131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41758373 |
132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39898762 |
133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38249024 |
134 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37298205 |
135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36017145 |
136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30626913 |
137 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28302949 |
138 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27748220 |
139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25339831 |
140 | Nicotine addiction_Homo sapiens_hsa05033 | 0.24802737 |
141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24245512 |
142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22355535 |